Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-trigonal OnabotulinumtoxinA Injections for Refractory IDO
NCT02009540Phase 4Unknown
- Start
- Dec 2013
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in idiopathic detrusor overactivity (IDO). Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
idiopathic detrusor overactivity (IDO)
Beyond the preview
Go deeper on NCT02009540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02009540.